DK572987D0 - Substituerede 1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem - Google Patents

Substituerede 1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem

Info

Publication number
DK572987D0
DK572987D0 DK572987A DK572987A DK572987D0 DK 572987 D0 DK572987 D0 DK 572987D0 DK 572987 A DK572987 A DK 572987A DK 572987 A DK572987 A DK 572987A DK 572987 D0 DK572987 D0 DK 572987D0
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
imidazoles
preparation
compounds
Prior art date
Application number
DK572987A
Other languages
English (en)
Other versions
DK572987A (da
DK166584B1 (da
Inventor
Eric Cossement
Jean-Pierre Geerts
Jean Gobert
Philippe Michel
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of DK572987D0 publication Critical patent/DK572987D0/da
Publication of DK572987A publication Critical patent/DK572987A/da
Application granted granted Critical
Publication of DK166584B1 publication Critical patent/DK166584B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK572987A 1986-11-04 1987-11-02 Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem DK166584B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626287A GB8626287D0 (en) 1986-11-04 1986-11-04 Substituted 1h-imidazoles
GB8626287 1986-11-04

Publications (3)

Publication Number Publication Date
DK572987D0 true DK572987D0 (da) 1987-11-02
DK572987A DK572987A (da) 1988-05-05
DK166584B1 DK166584B1 (da) 1993-06-14

Family

ID=10606751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572987A DK166584B1 (da) 1986-11-04 1987-11-02 Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem

Country Status (24)

Country Link
US (1) US4814343A (da)
EP (1) EP0269599B1 (da)
JP (1) JP2632877B2 (da)
KR (1) KR910003116B1 (da)
AT (1) ATE98640T1 (da)
AU (1) AU592733B2 (da)
CA (1) CA1301174C (da)
CY (1) CY1845A (da)
DE (1) DE3788507T2 (da)
DK (1) DK166584B1 (da)
ES (1) ES2060608T3 (da)
FI (1) FI91858C (da)
GB (1) GB8626287D0 (da)
HK (1) HK78895A (da)
HU (1) HU206684B (da)
IE (1) IE61901B1 (da)
IL (1) IL84322A (da)
MY (1) MY102578A (da)
NO (1) NO169960C (da)
NZ (1) NZ222382A (da)
PL (3) PL155119B1 (da)
PT (1) PT86040B (da)
SU (4) SU1662349A3 (da)
ZA (1) ZA878170B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0336759A1 (en) * 1988-04-07 1989-10-11 Glaxo Group Limited Imidazole derivatives
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
JPH04252867A (ja) * 1991-01-25 1992-09-08 Nissan Motor Co Ltd 内燃機関の燃料供給装置
GB9310965D0 (en) * 1993-05-27 1993-07-14 Ucb Sa 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US8119807B2 (en) * 2007-01-12 2012-02-21 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
WO2008088936A1 (en) * 2007-01-12 2008-07-24 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
WO2008086131A1 (en) * 2007-01-12 2008-07-17 Allergan, Inc. Naphthylmethylimidizoles as therapeutic agents
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
KR20260023049A (ko) * 2023-06-19 2026-02-20 지앙수 엔화 파마수티컬 컴퍼니 리미티드 치환된 이미다졸 유도체, 중간체, 제조 방법 및 이의 응용
CN120865095A (zh) * 2025-07-04 2025-10-31 武穴宏源药业有限公司 一种咪唑环合液的提纯方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29761A (en) * 1860-08-28 Improvements in telegraphic apparatus
US4070472A (en) 1974-02-07 1978-01-24 Smith Kline & French Laboratories Limited Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE4224020A1 (de) * 1992-07-22 1994-01-27 Deutsche Aerospace Verfahren zur Auslösung der Zündung eines Gefechtskopfes und Anordnung zum Durchführen des Verfahrens

Also Published As

Publication number Publication date
DK572987A (da) 1988-05-05
IL84322A0 (en) 1988-03-31
KR910003116B1 (ko) 1991-05-18
MY102578A (en) 1992-07-31
EP0269599A3 (en) 1990-03-14
JP2632877B2 (ja) 1997-07-23
NO874572D0 (no) 1987-11-03
DE3788507D1 (de) 1994-01-27
FI91858B (fi) 1994-05-13
DK166584B1 (da) 1993-06-14
EP0269599B1 (fr) 1993-12-15
IL84322A (en) 1991-08-16
ZA878170B (en) 1989-07-26
FI874789L (fi) 1988-05-05
FI91858C (fi) 1994-08-25
GB8626287D0 (en) 1986-12-03
HUT56547A (en) 1991-09-30
AU8059387A (en) 1988-05-05
PT86040A (pt) 1987-11-01
IE872963L (en) 1988-05-04
CY1845A (en) 1996-03-08
CA1301174C (en) 1992-05-19
AU592733B2 (en) 1990-01-18
US4814343A (en) 1989-03-21
ATE98640T1 (de) 1994-01-15
NZ222382A (en) 1991-07-26
DE3788507T2 (de) 1994-05-19
ES2060608T3 (es) 1994-12-01
JPS63132876A (ja) 1988-06-04
NO874572L (no) 1988-05-05
SU1628857A3 (ru) 1991-02-15
FI874789A0 (fi) 1987-10-30
NO169960B (no) 1992-05-18
NO169960C (no) 1992-08-26
PL156483B1 (en) 1992-03-31
PT86040B (pt) 1990-07-31
PL156482B1 (pl) 1992-03-31
SU1635899A3 (ru) 1991-03-15
PL268558A1 (en) 1988-09-01
EP0269599A2 (fr) 1988-06-01
PL155119B1 (en) 1991-10-31
SU1662349A3 (ru) 1991-07-07
SU1710558A1 (ru) 1992-02-07
HK78895A (en) 1995-05-26
HU206684B (en) 1992-12-28
KR880006205A (ko) 1988-07-22
IE61901B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
DK572987A (da) Substituerede 1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem
KR870011101A (ko) 신규 헤테로시클릭 화합물의 제조방법
ES8401035A1 (es) "metodo de preparar compuestos benzoheterociclicos".
IE811250L (en) Imidazole derivatives
ES8406440A1 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
EP0322738A3 (en) Benzylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells
NO20022232L (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
KR860005794A (ko) 이미다졸 유도체의 제조방법
MY101940A (en) Chemical compounds
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
DK0967207T3 (da) Nitron-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne
DE3572808D1 (en) 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds
ES8106725A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
AU557772B2 (en) I-furyl-3,4-dihydroisoquinolines
ES8105004A1 (es) Procedimiento de preparar compuestos pirimidinicos condensa-dos con cabeza de puente de nitrogeno
IE821475L (en) Benzoyl-phenyl-piperidine derivatives
DE68915484D1 (de) Sulfonylindolizinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Synthese-Zwischenprodukte.
DK389683D0 (da) Fremgangsmade til fremstilling af substituerede 1,3,4-benzotriazepiner eller farmaceutisk acceptable syreadditionssalte deraf
KR830001237A (ko) 신규 이미다졸(imtdazole)화합물 및 그것을 함유하는 항울제(抗鬱劑)